MONTE ROSA THERAPEUTICS INC (GLUE) Stock News
USA - NASDAQ:GLUE - US61225M1027 - Common Stock
10.65 USD
+0.04 (+0.38%)
GLUE Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Stocktwits - Mentions: NVS
a month ago - By: Monte Rosa Therapeutics, Inc.
a month ago - By: Monte Rosa Therapeutics, Inc.
a month ago - By: Monte Rosa Therapeutics, Inc.
a month ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: The Motley Fool - Mentions: NVS
2 months ago - By: Zacks Investment Research - Mentions: IRD
2 months ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: Zacks Investment Research - Mentions: CERT
3 months ago - By: Monte Rosa Therapeutics, Inc.
3 months ago - By: Monte Rosa Therapeutics, Inc.
3 months ago - By: Monte Rosa Therapeutics, Inc.
3 months ago - By: Monte Rosa Therapeutics, Inc.
4 months ago - By: Monte Rosa Therapeutics, Inc.
4 months ago - By: Monte Rosa Therapeutics, Inc.
5 months ago - By: Monte Rosa Therapeutics, Inc.
5 months ago - By: Zacks Investment Research - Mentions: IGMS
5 months ago - By: Monte Rosa Therapeutics, Inc.
5 months ago - By: Zacks Investment Research - Mentions: TCRX
7 months ago - By: Monte Rosa Therapeutics, Inc.
7 months ago - By: Monte Rosa Therapeutics, Inc.